| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 02/22/2001 | CA2380940A1 Substances and agents for positively influencing collagen |
| 02/22/2001 | CA2380817A1 Cell adhesion inhibitors |
| 02/22/2001 | CA2380786A1 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/22/2001 | CA2380642A1 Compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| 02/22/2001 | CA2378332A1 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 02/21/2001 | EP1077218A2 Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors |
| 02/21/2001 | EP1076703A2 Il-17 homologous polypeptides and therapeutic uses thereof |
| 02/21/2001 | EP1076702A1 Human protease associated proteins |
| 02/21/2001 | EP1076699A2 Method of inhibiting osteoclast activity |
| 02/21/2001 | EP1076641A1 Inhibitors of impdh enzyme |
| 02/21/2001 | CN1284997A Modified deacetoxycephalosporin C synthase (DAOCS) and x-ray structure |
| 02/21/2001 | CN1284950A Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists |
| 02/21/2001 | CN1284947A Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
| 02/21/2001 | CN1284945A Substituted pyriding and pyridazine compounds and their pharmaceutical use |
| 02/21/2001 | CN1284944A Integrin receptor antagonists |
| 02/21/2001 | CN1284943A Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
| 02/21/2001 | CN1284942A Matrix metalloprotease inhibitors |
| 02/21/2001 | CN1284870A Utilization of alkyl hydrogen fumerates for treating psoriasis, psoriatic arthritis, neurodermatitis and regional enteritis |
| 02/21/2001 | CN1284863A Topical compositions for NSAI drug delivery |
| 02/21/2001 | CN1284365A Fracture treating plaster |
| 02/21/2001 | CN1284352A Application of breviscapine seoul wildginger herb oral preparation in pharmacy |
| 02/21/2001 | CN1284346A Far infrared Gukangtie plaster |
| 02/21/2001 | CN1062179C Method of preparing plaster for prolapse of lumbar intervertebral disc |
| 02/21/2001 | CN1062175C Medicinal wine and its making method |
| 02/21/2001 | CN1062172C Medicine for treating cervical spondylopathy |
| 02/21/2001 | CN1062159C Ointment of treatment of heperosteogeny and its prep. |
| 02/21/2001 | CN1062151C Medicinal compsn. for treatment of heperosteogeny and its prepn. |
| 02/21/2001 | CN1062149C Marmot bone wine for curing rheumatism |
| 02/20/2001 | US6191304 Vitronectin receptor antagonists |
| 02/20/2001 | US6191271 Synthetic divalent sLex containing polylactosamines and methods for use |
| 02/20/2001 | US6191160 Spiro-indolines as Y5 receptor antagonists |
| 02/20/2001 | US6191135 Respiratory system disorders, antiinflammatory agents; analgesics |
| 02/20/2001 | US6190880 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| 02/20/2001 | US6190695 Preventing or treating various bone diseases (e.g., osteoporosis); oral absorbability and stability |
| 02/20/2001 | US6190665 Calcium channel antagonist possessing an inhibitory action against secretion of parathyroid hormones and a use thereof |
| 02/20/2001 | CA2302629C Estrogen receptor |
| 02/20/2001 | CA2223624C Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-.alpha.]pyridines |
| 02/20/2001 | CA2192289C Substituted heterocyclic derivatives |
| 02/15/2001 | WO2001011050A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY |
| 02/15/2001 | WO2001011046A1 Dendritic enriched secreted lymphocyte activation molecule |
| 02/15/2001 | WO2001011041A1 MONOMERIC PROTEIN OF THE TGF-β FAMILY |
| 02/15/2001 | WO2001011023A1 Treatment of inflammatory or malignant disease using dnazymes |
| 02/15/2001 | WO2001010873A1 Novel 2-decarboxy-2-phosphinico prostaglandin f analogs |
| 02/15/2001 | WO2001010865A1 p38MAP KINASE INHIBITORS |
| 02/15/2001 | WO2001010859A1 Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity |
| 02/15/2001 | WO2001010847A2 Novel integrin receptor antagonists |
| 02/15/2001 | WO2001010841A2 Fluorene derivatives as integrin inhibitors |
| 02/15/2001 | WO2001010829A1 Novel vitamin d analogues |
| 02/15/2001 | WO2001010827A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 02/15/2001 | WO2001010463A1 Pastes with the sustained release of osteogenesis promoter |
| 02/15/2001 | WO2001010430A2 Use of estrogen compounds for prevention and treatment of ischemic damage |
| 02/15/2001 | WO2001010427A2 Use of anti-muscarinic agents for treating skin disorders |
| 02/15/2001 | WO2001010413A2 Periodic structures comprising lipids, polyelectrolytes, and structures-inducing soluble oligovalent linkers |
| 02/15/2001 | WO2001010392A2 Composition for restoring defects in calcified tissues |
| 02/15/2001 | WO2001010381A2 Methods for treating or preventing pain and anxiety |
| 02/15/2001 | WO2000068385A3 Novel nucleic acids and proteins with growth hormone activity |
| 02/15/2001 | WO2000066584B1 1-AMINO TRIAZOLO¢4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV |
| 02/15/2001 | WO2000065054A3 Human membrane-associated proteins |
| 02/15/2001 | WO2000064874A3 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
| 02/15/2001 | WO2000057920A3 Method for expressing proteins |
| 02/15/2001 | WO2000054759A3 Lxr modulators |
| 02/15/2001 | WO2000049144A3 Pyk2 binding proteins |
| 02/15/2001 | WO1999046366A8 Uses for humane non-autologous mesenchymal stem cells |
| 02/15/2001 | DE19936780A1 Neue Antagonisten von Integrinrezeptoren New antagonists of integrin |
| 02/15/2001 | CA2382659A1 Dendritic enriched secreted lymphocyte activation molecule |
| 02/15/2001 | CA2381910A1 Novel vitamin d analogues |
| 02/15/2001 | CA2381621A1 Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity |
| 02/15/2001 | CA2381284A1 Fhm, a novel member of the tnf ligand supergene family |
| 02/15/2001 | CA2381215A1 P38map kinase inhibitors |
| 02/15/2001 | CA2380981A1 Fluorene derivatives |
| 02/15/2001 | CA2380678A1 Treatment of inflammatory or malignant disease using dnazymes |
| 02/15/2001 | CA2379977A1 Novel integrin receptor antagonists |
| 02/15/2001 | CA2378486A1 Osteogenesis promoter sustained-release paste |
| 02/15/2001 | CA2378445A1 Use of anti-muscarinic agents for treating skin disorders |
| 02/15/2001 | CA2378310A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 02/15/2001 | CA2377422A1 Periodic structures comprising lipids, polyelectrolytes, and structure- inducing soluble oligovalent linkers, and biological use thereof |
| 02/15/2001 | CA2348959A1 Methods of cytoprotection using an enantiomer of estrogen of ischemic damage |
| 02/14/2001 | EP1075528A1 Endothelin-converting-enzyme like protein |
| 02/14/2001 | EP1075496A1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis |
| 02/14/2001 | EP1075493A2 Dna encoding snorf25 receptor |
| 02/14/2001 | EP1075489A2 Water-soluble pro-drugs of 2,6-diisopropylphenol analogues |
| 02/14/2001 | EP1075476A1 Novel benzimidazoles and benzoxazoles |
| 02/14/2001 | EP1075475A1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production |
| 02/14/2001 | EP1075472A1 Prodrugs of benzofuranylmethyl carbamate nk 1? antagonists |
| 02/14/2001 | EP1075467A1 Pyrazole derivatives as p-38 map kinase inhibitors |
| 02/14/2001 | EP1075256A1 Arylhydrocarbon receptor ligand antagonists |
| 02/14/2001 | EP1075255A1 Inhibition of binding of hox and homeodomain-containing proteins and uses thereof |
| 02/14/2001 | EP0968226A4 G-rich oligo aptamers and methods of modulating an immune response |
| 02/14/2001 | EP0844874A4 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF ALPHA v BETA 5 MEDIATED ANGIOGENESIS |
| 02/14/2001 | EP0643071B1 Compound for inhibiting bone resorption and accelerating osteogenesis |
| 02/14/2001 | CN1284134A Methods of producing anti-angiogenic proteins: endostation, angiostation or restin, using pichia yeast expression system |
| 02/14/2001 | CN1284130A Mutants of endostation, 'EM1' having ant-angiogenic activety and methods of use thereof |
| 02/14/2001 | CN1284064A 2,3-substituted indole compounds as cox-2 inhibitors |
| 02/14/2001 | CN1284057A Adamantane derivatives |
| 02/14/2001 | CN1283622A 6-hydroxy-3(4-[2-(piperidine-1-group)oxyethyl group]phenoxy)-2-(4-methoxy phenyl) benzo[b] thiophene hydrochloride salt |
| 02/14/2001 | CN1283495A Chinese medicine for treating narrow lumbar vetebra canal without operation |
| 02/14/2001 | CN1061890C Traditional chinese medicinal powder for treating stasis and improving blood circulation |
| 02/14/2001 | CN1061884C Chinese medicine for treating ischemic necrosis of thighbone head |
| 02/14/2001 | CN1061880C Pill for improving appetite diminishing-stagnant of blood and removing obstruction in channels and its prefon method |
| 02/14/2001 | CN1061871C Wind-expelling and pain-alleviating drug for external use |